Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab

NCT01009918 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

468

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Cardiac Toxicity

Interventions

DRUG: Coreg CR®
DRUG: lisinopril
OTHER: placebo

Sponsor

University of South Florida

Collaborators

[object Object]